Extended (D2) Lymph Node Dissection for Gastric Cancer: Do Patients Benefit?
- 1 May 2000
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 7 (4) , 253-255
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Evidence‐based Surgery: A Passing Fad?World Journal of Surgery, 1999
- Lymph-Node Dissection for Gastric CancerNew England Journal of Medicine, 1999
- Extended Lymph-Node Dissection for Gastric CancerNew England Journal of Medicine, 1999
- Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trialBritish Journal of Cancer, 1999
- Current Advances and Changes in Treatment Strategy May Improve Survival and Quality of Life in Patients With Potentially Curable Gastric CancerAnnals of Surgical Oncology, 1999
- Relevant Prognostic Factors in Gastric CancerAnnals of Surgery, 1998
- Evidence of survival benefit of extended (D2) lymphadenectomy in Western patients with gastric cancer based on a new concept: A prospective long-term follow-up studySurgery, 1998
- Incidence of nodal metastasis around the superior border of the pancreas based on number of metastatic perigastric nodesGastric Cancer, 1998
- Evidence based medicine: what it is and what it isn'tBMJ, 1996
- Progress in gastric cancer surgery in Japan and its limits of radicalityWorld Journal of Surgery, 1987